[HTML][HTML] Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis

IL Alberts, SE Seide, C Mingels, KP Bohn, K Shi… - European journal of …, 2021 - Springer
Purpose Many radiotracers are currently available for the detection of recurrent prostate
cancer (rPC), yet many have not been compared head-to-head in comparative imaging …

Using PSMA imaging for prognostication in localized and advanced prostate cancer

MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …

[HTML][HTML] 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

M Sathekge, F Bruchertseifer, O Knoesen… - European journal of …, 2019 - Springer
Background A remarkable therapeutic efficacy has been demonstrated with 225 Ac-prostate-
specific membrane antigen (PSMA)-617 in heavily pre-treated metastatic castration-resistant …

[HTML][HTML] 68Ga-PSMA PET/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a …

LL Zhang, WC Li, Z Xu, N Jiang, SM Zang… - European Journal of …, 2021 - Springer
Purpose 68 Ga-prostate-specific membrane antigen (PSMA) positron emission
tomography/computed tomography (PET/CT) is valuable for detecting primary and recurrent …

[HTML][HTML] Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in …

K Subramanian, J Martinez… - Scientific Reports, 2023 - nature.com
Prostate cancer (PC) staging with conventional imaging often includes multiparametric
magnetic resonance (MR) of the prostate, computed tomography (CT) of the chest …

The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer

MA Hoffmann, HJ Wieler, C Baues, NJ Kuntz… - Urology, 2019 - Elsevier
Prostate-specific membrane antigen (PSMA) is a transmembrane protein with significantly
increased expression in the cells and metastases of prostate carcinoma (CaP). PSMA …

[HTML][HTML] Comparing the clinical performance and cost efficacy of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov …

I Alberts, C Mingels, HD Zacho, S Lanz… - European journal of …, 2021 - Springer
Abstract Purpose Amongst others,[68 Ga] Ga-PSMA-11 and [18 F] PSMA-1007 are available
for the detection of recurrent prostate cancer (rPC). There are currently limited data …

[HTML][HTML] Comparing 99mTc-PSMA to 99mTc-MDP in prostate cancer staging of the skeletal system

J Kabunda, L Gabela, C Kalinda, C Aldous… - Clinical Nuclear …, 2021 - journals.lww.com
Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging... : Clinical Nuclear
Medicine Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal …

A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide …

IO Lawal, KMG Mokoala, J Mahapane… - European Journal of …, 2021 - Springer
Abstract Purpose Prostate cancer (PCa) commonly metastasizes to the bones. There are
several radionuclide techniques for imaging PCa skeletal metastases. We aimed to compare …

Prognostic value of PSMA PET/CT in prostate cancer

IO Lawal, H Ndlovu, M Kgatle, KMG Mokoala… - Seminars in Nuclear …, 2023 - Elsevier
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …